Brad Dieter

CEO at Ethoderm

Brad Dieter is an expert in physiology, molecular biology, and biomedical science, Brad Dieter recently finished his fellowship training in discovering novel therapeutics. Dr. Dieter’s research adopts a bench-to-bedside approach; adeptly utilizing molecular biology tools and his advanced training in biostatistics to discover and develop novel therapeutic agents for disease. In addition to his scientific career and training, he has been involved in building several businesses in the health-technology and biotechnology space through work as an executive and on scientific advisory boards.

Timeline

  • CEO

    Current role

  • Chairman